These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6385624)

  • 41. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
    DiGiovanni J; Rho O; Xian W; Beltràn L
    Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natural history of carcinogenesis: implications of experimental carcinogenesis in the genesis of human cancer.
    Pitot HC; Goldsworthy T; Moran S
    J Supramol Struct Cell Biochem; 1981; 17(2):133-46. PubMed ID: 7033553
    [No Abstract]   [Full Text] [Related]  

  • 43. Current concepts and controversies in chemical carcinogenesis.
    Weinstein IB
    J Supramol Struct Cell Biochem; 1981; 17(2):99-120. PubMed ID: 7033554
    [No Abstract]   [Full Text] [Related]  

  • 44. Teleocidin: new naturally occurring tumor promoter.
    Sugimura T; Fujiki H; Mori M; Nakayasu M; Terada M; Umezawa K; Moore RE
    Carcinog Compr Surv; 1982; 7():69-73. PubMed ID: 6802497
    [No Abstract]   [Full Text] [Related]  

  • 45. Nature of the epidermal hyperplasia produced by mezerein, a weak tumor promoter, in initiated skin of mice.
    Argyris TS
    Cancer Res; 1983 Apr; 43(4):1768-73. PubMed ID: 6403228
    [No Abstract]   [Full Text] [Related]  

  • 46. Co-carcinogenesis.
    Clayson DB
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():35-51. PubMed ID: 6385621
    [No Abstract]   [Full Text] [Related]  

  • 47. Analysis of modifying factors in chemical carcinogenesis.
    Cohen SM
    Prog Exp Tumor Res; 1991; 33():21-40. PubMed ID: 2028024
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative mutagenicity, tumor-initiating activity, carcinogenicity, and in vitro metabolism of fluorinated 5-methylchrysenes.
    Hecht SS; LaVole E; Mazzarese R; Hirota N; Ohmori T; Hoffmann D
    J Natl Cancer Inst; 1979 Sep; 63(3):855-61. PubMed ID: 288940
    [No Abstract]   [Full Text] [Related]  

  • 49. Strain-specific tumorigenesis in mouse skin induced by the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, and its relation to DNA adduct formation and persistence.
    Abbott PJ
    Cancer Res; 1983 May; 43(5):2261-6. PubMed ID: 6831449
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Specific binding of phorbol ester tumor promoters to mouse skin.
    Delclos KB; Nagle DS; Blumberg PM
    Cell; 1980 Apr; 19(4):1025-32. PubMed ID: 7379122
    [No Abstract]   [Full Text] [Related]  

  • 51. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication No. 13. The need for biological risk assessment in reaching decisions about carcinogens.
    Clayson DB
    Mutat Res; 1987 May; 185(3):243-69. PubMed ID: 3574332
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parallel orders of reactivity in murine cells of mezerein and phorbol esters toward the mixed-lymphocyte response and promotion of tumorigenesis.
    Baxter CS; Fish LA; Bash JA
    Toxicol Appl Pharmacol; 1981 Jun; 59(1):173-6. PubMed ID: 6454989
    [No Abstract]   [Full Text] [Related]  

  • 53. [Role of cell-cell interaction in tumor promotion].
    Yamasaki H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):773-81. PubMed ID: 3963844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Receptor-mediated biological processes: implications for evaluating carcinogens.
    Silbergeld E
    Prog Clin Biol Res; 1994; 387():273-93. PubMed ID: 7972252
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of initiated cells as a test system for the detection of inhibitors of gap junctional intercellular communication.
    Jansen LA; Jongen WM
    Carcinogenesis; 1996 Feb; 17(2):333-9. PubMed ID: 8625460
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The protein kinase C pathway in tumor promotion.
    Blumberg PM; Pettit GR; Warren BS; Szallasi A; Schuman LD; Sharkey NA; Nakakuma H; Dell'Aquila ML; de Vries DJ
    Prog Clin Biol Res; 1989; 298():201-12. PubMed ID: 2748684
    [No Abstract]   [Full Text] [Related]  

  • 57. Okadaic acid and phorbol esters: comparative effects of these tumor promoters on cell transformation, intercellular communication and differentiation in vitro.
    Katoh F; Fitzgerald DJ; Giroldi L; Fujiki H; Sugimura T; Yamasaki H
    Jpn J Cancer Res; 1990; 81(6-7):590-7. PubMed ID: 2119362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor promotion by phorbol esters in skin: evidence for a memory effect.
    Fürstenberger G; Sorg B; Marks F
    Science; 1983 Apr; 220(4592):89-91. PubMed ID: 6828884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indole-3-carbinol: anticarcinogen or tumor promoter in brassica vegetables?
    Dashwood RH
    Chem Biol Interact; 1998 Mar; 110(1-2):1-5. PubMed ID: 9566721
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW; Estensen RD
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.